Price of Mounjaro to be discounted in UK pharmacies
Price of Mounjaro to be discounted in UK pharmacies
The rebate allays fears of a 170% price rise but patients are warned the cost of the drug will still jump.
Read the full article on BBC Health
Truth Analysis
Analysis Summary:
The article's claim about a price discount for Mounjaro in UK pharmacies is generally supported, but the extent and specific details are somewhat unclear and potentially exaggerated. There's a moderate bias towards highlighting the positive aspect of the discount while downplaying the overall cost increase. The claim about a 170% price rise is not directly verifiable from the provided sources, but the sources do indicate a price increase was expected.
Detailed Analysis:
- Claim: Price of Mounjaro to be discounted in UK pharmacies.
- Verification Source #2: Confirms a discount scheme from Eli Lilly to pharmacies.
- Verification Source #4: Reports price cuts by British pharmacies for Mounjaro and Wegovy.
- Assessment: Supported, but the magnitude of the discount needs further context.
- Claim: The rebate allays fears of a 170% price rise.
- Verification Source #5: Indicates a price increase was scheduled for September 1, 2025.
- Assessment: Partially supported. Source 5 confirms a price increase was planned, but the 170% figure is not directly verified by any source. The rebate suggests an attempt to mitigate the impact of this increase.
- Claim: Patients are warned the cost of the drug will still jump.
- Verification Source #2: Implies a price increase even with the discount.
- Assessment: Supported. The discount doesn't negate the overall increase in cost.
Supporting Evidence/Contradictions:
- Source 2: "A confidential document from the makers Eli Lilly to pharmacies sets out the scheme, with a saving of £83 on the cost of the maximum…"
- Source 5: "List prices of the weight-loss drug Mounjaro (tirzepatide) KwikPen will increase from 1 September 2025 for private prescriptions in the UK…"